LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

Search

Artivion Inc

Cerrado

SectorSalud

30.83 2.05

Resumen

Variación precio

24h

Actual

Mínimo

29.57

Máximo

30.74

Métricas clave

By Trading Economics

Ingresos

16M

-505K

Ventas

1.7M

99M

BPA

-0.012

Margen de beneficio

-0.51

Empleados

1,600

EBITDA

2.7M

2.1M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+9.09% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

333M

1.3B

Apertura anterior

28.78

Cierre anterior

30.83

Noticias sobre sentimiento de mercado

By Acuity

35%

65%

88 / 381 Clasificación en Healthcare

Artivion Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

20 jun 2025, 18:52 UTC

Ganancias

Accenture Shares Fall on Bookings Decline, Concerns over Federal Government Contract -- 3rd Update

22 jun 2025, 23:59 UTC

Charlas de Mercado

Gold Edges Higher Amid Worries Over Middle East Conflict -- Market Talk

22 jun 2025, 23:55 UTC

Charlas de Mercado

Markets Wait to See if Iran's Response Will be Symbolic or Substantial -- Market Talk

22 jun 2025, 23:51 UTC

Charlas de Mercado

Oil Climbs After U.S. Attack on Iran's Nuclear Sites -- Market Talk

22 jun 2025, 23:43 UTC

Charlas de Mercado

Reasons to Believe Strait of Hormuz Will Remain Open -- Market Talk

22 jun 2025, 23:38 UTC

Charlas de Mercado

Nikkei May Fall as Middle East Uncertainty Persists -- Market Talk

22 jun 2025, 23:11 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 jun 2025, 23:11 UTC

Charlas de Mercado

Early Market Reaction to Iran Attacks Restrained -- Market Talk

22 jun 2025, 22:59 UTC

Charlas de Mercado

Gold, Silver Rise as Investors Seek Haven After Strikes on Iran -- Market Talk

22 jun 2025, 21:43 UTC

Charlas de Mercado

Australian Govt Says Supports US Strikes On Iran -- Market Talk

21 jun 2025, 08:20 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

21 jun 2025, 08:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

21 jun 2025, 08:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

20 jun 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

20 jun 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

20 jun 2025, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

20 jun 2025, 20:13 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Moved the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20 jun 2025, 20:11 UTC

Charlas de Mercado

Natural Gas Slides in Late-Week Profit Taking -- Market Talk

20 jun 2025, 19:56 UTC

Charlas de Mercado

Crude Oil Slips to End Week -- Market Talk

20 jun 2025, 18:35 UTC

Charlas de Mercado

Warehouse Clubs Seen Growing Market Share -- Market Talk

20 jun 2025, 18:12 UTC

Charlas de Mercado

Gold Slides to Close Shortened Week -- Market Talk

20 jun 2025, 17:56 UTC

Charlas de Mercado

Baker Hughes Reports Slight Decrease in U.S. Rig Count -- Market Talk

20 jun 2025, 17:50 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20 jun 2025, 17:35 UTC

Adquisiciones, fusiones, absorciones

Cisco Was the Dot-Com Bust's Biggest Loser. Now It's at a 25-Year High. -- Barrons.com

20 jun 2025, 17:30 UTC

Charlas de Mercado
Ganancias

Adobe's AI Headwinds Seen Fading -- Market Talk

20 jun 2025, 17:03 UTC

Ganancias

Accenture Earnings Beat Expectations. Why the Stock Is Falling Anyway. -- Barrons.com

20 jun 2025, 16:50 UTC

Charlas de Mercado
Ganancias

Global Equities Roundup: Market Talk

20 jun 2025, 16:50 UTC

Charlas de Mercado
Ganancias

Accenture Seeing Companies Shift to Leapfrog Mentality -- Market Talk

20 jun 2025, 16:44 UTC

Adquisiciones, fusiones, absorciones

Meet QXO, the Upstart Building Materials Stock That May Battle Home Depot for GMS -- Barrons.com

20 jun 2025, 16:40 UTC

Charlas de Mercado
Ganancias

Accenture Can't Yet Estimate Longer Term Impact from Federal Cuts -- Market Talk

Comparación entre iguales

Cambio de precio

Artivion Inc Esperado

Precio Objetivo

By TipRanks

9.09% repunte

Estimación a 12 meses

Media 33 USD  9.09%

Máximo 35 USD

Mínimo 30 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Artivion Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

5

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

88 / 381 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Artivion Inc

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.